Protein for New TB Vaccine

  • Author: ChemistryViews
  • Published: 24 March 2011
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Proc. Natl. Acad. Sci./National Academy of Sciences
thumbnail image: Protein for New TB Vaccine

Tuberculosis (TB) is caused by the bacteria Mycobacterium tuberculosis (MTB). The vaccine against TB is produced from Mycobacterium bovis bacterium, which is related to MTB and infects cattle. Differences between the strains means that this vaccine, Bacillus Calmette-Guérin (BCG), is of limited effectiveness against TB. However, it is the only vaccine available.

Ajit Lalvani and colleagues, Imperial College London, UK, have identified a protein, called EspC, that triggers a stronger immune response in TB sufferers than any other known molecule. The protein is secreted by MTB but not by the Mycobacterium bovis bacterium. As a result, the BCG vaccine does not induce an immune response to this protein. Development of a vaccine based on EspC would provide additional immunity to that provided by BCG.

EspC could also be useful as a diagnostic tool, because it provokes an immune response in TB-infected people, but not in vaccinated people.

► Also see:

Article Views: 3560

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from, please contact us first for permission and consult our permission guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH